Multiple sclerosis – References

Acknowledgements

This evidence summary was written by:

William B. Grant, Ph.D.
Sunlight, Nutrition, and Health Research Center (SUNARC)
P.O. Box 641603
San Francisco, CA 94164-1603, USA       
www.sunarc.org       
wbgrant@infionline.net

The summary was reviewed by:

Ashton Embrey <Ashton.Embry@NRCan-RNCan.gc.ca>
Sreeram Ramagopalan <sramagopalan@gmail.com>
Barbara M van Amerongen <b.m.van.amerongen@inter.nl.net>

Complete bibliography of research used in this summary

We found a significant body of evidence when researching the role of vitamin D in multiple sclerosis.  The research we have cited in our summary is listed below, with links to PubMed abstracts and full-text for those who wish to explore further.

12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667

Page last edited: 05 May 2011

References

  1. Ascherio, A. Munger, K. Epidemiology of multiple sclerosis: from risk factors to prevention. Semin Neurol. 2008 Feb; 28 (1): 17-28.
  2. Ascherio, A. Munger, K. L. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence. Clin Exp Immunol. 2010 Apr; 160 (1): 120-4.
  3. Ascherio, A. Munger, K. L. Epstein-barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol. 2010 Sep; 5 (3): 271-7.
  4. Ascherio, A. Munger, K. L. Simon, K. C. Vitamin D and multiple sclerosis. Lancet Neurol. 2010 Jun; 9 (6): 599-612.
  5. Auer, D. P. Schumann, E. M. Kumpfel, T. Gossl, C. Trenkwalder, C. Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000 Feb; 47 (2): 276-7.
  6. Baeke, F. Takiishi, T. Korf, H. Gysemans, C. Mathieu, C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010 Aug; 10 (4): 482-96.
  7. Bagert, B. A. Epstein-Barr virus in multiple sclerosis. Curr Neurol Neurosci Rep. 2009 Sep; 9 (5): 405-10.
  8. Bartosik-Psujek, H. Tabarkiewicz, J. Pocinska, K. Stelmasiak, Z. Rolinski, J. Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis. Mult Scler. 2010 Aug 25;
  9. Burton, J. M. Kimball, S. Vieth, R. Bar-Or, A. Dosch, H. M. Cheung, R. Gagne, D. D’Souza, C. Ursell, M. O’Connor, P. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology. 2010 Jun 8; 74 (23): 1852-9.
  10. Cantorna, M. T. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol. 2006 Sep; 92 (1): 60-4.
  11. Cantorna, M. T. Vitamin D and multiple sclerosis: an update. Nutr Rev. 2008 Oct; 66 (10 Suppl 2): S135-8.
  12. Cantorna, M. T. Hayes, C. E. DeLuca, H. F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A. 1996 Jul 23; 93 (15): 7861-4.
  13. Cantorna, M. T. Mahon, B. D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004 Dec; 229 (11): 1136-42.
  14. Compston, A. Coles, A. Multiple sclerosis. Lancet. 2008 Oct 25; 372 (9648): 1502-17.
  15. Craelius, W. Comparative epidemiology of multiple sclerosis and dental caries. J Epidemiol Community Health. 1978 Sep; 32 (3): 155-65.
  16. Douglas, A. S. Brown, T. Reid, D. Infectious mononucleosis and Hodgkin’s disease–a similar seasonality. Leuk Lymphoma. 1996 Oct; 23 (3-4): 323-31.
  17. Edlich, R. F. Mason, S. S. Reddig, J. S. Gubler, K. Long, W. B., 3rd A case report: femoral fracture in a multiple sclerosis patient with vitamin d deficiency–a preventable injury. J Environ Pathol Toxicol Oncol. 2010; 29 (1): 3-5.
  18. Embry, A. F. Snowdon, L. R. Vieth, R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000 Aug; 48 (2): 271-2.
  19. Feron, F. Vitamin D and multiple sclerosis: what are the guidelines for a reliable clinical trial?. Expert Rev Neurother. 2010 Sep; 10 (9): 1375-8.
  20. Goldberg, P. Fleming, M. C. Picard, E. H. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses. 1986 Oct; 21 (2): 193-200.
  21. Goodin, D. S. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One. 2009; 4 (2): e4565.
  22. Grant, W. B. Hypothesis–ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem Photobiol. 2008 Mar-Apr; 84 (2): 356-65.
  23. Grant, W. B. The prevalence of multiple sclerosis in 3 US communities: the role of vitamin D. Prev Chronic Dis. 2010 Jul; 7 (4): A89; author reply A90.
  24. Grant, W. B. Garland, C. F. Holick, M. F. Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem Photobiol. 2005 Nov-Dec; 81 (6): 1276-86.
  25. Grant, W. B. Holick, M. F. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005 Jun; 10 (2): 94-111.
  26. Handel, A. E. Giovannoni, G. Ebers, G. C. Ramagopalan, S. V. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol. 2010 Mar; 6 (3): 156-66.
  27. Handel, A. E. Handunnetthi, L. Giovannoni, G. Ebers, G. C. Ramagopalan, S. V. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol. 2010 Sep; 17 (9): 1210-4.
  28. Handel, A. E. Ramagopalan, S. V. Multiple sclerosis and risk of cancer: a meta-analysis. J Neurol Neurosurg Psychiatry. 2010 Aug 19;
  29. Handunnetthi, L. Ramagopalan, S. V. Ebers, G. C. Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology. 2010 Jun 8; 74 (23): 1905-10.
  30. Hanwell, H. E. Banwell, B. Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim Biophys Acta. 2010 Jul 30;
  31. Hayes, C. E. Cantorna, M. T. DeLuca, H. F. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med. 1997 Oct; 216 (1): 21-7.
  32. Holmoy, T. Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis. Med Hypotheses. 2008; 70 (1): 66-9.
  33. Holmoy, T. Moen, S. M. Gundersen, T. A. Holick, M. F. Fainardi, E. Castellazzi, M. Casetta, I. 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler. 2009 Nov; 15 (11): 1280-5.
  34. Jin, Y. de Pedro-Cuesta, J. Soderstrom, M. Stawiarz, L. Link, H. Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. J Neurol Sci. 2000 Dec 1; 181 (1-2): 56-64.
  35. Kampman, M. T. Steffensen, L. H. The role of vitamin D in multiple sclerosis. J Photochem Photobiol B. 2010 Nov 3; 101 (2): 137-41.
  36. Killestein, J. Rep, M. H. Meilof, J. F. Ader, H. J. Uitdehaag, B. M. Barkhof, F. van Lier, R. A. Polman, C. H. Seasonal variation in immune measurements and MRI markers of disease activity in MS. Neurology. 2002 Apr 9; 58 (7): 1077-80.
  37. Koch-Henriksen, N. Sorensen, P. S. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010 May; 9 (5): 520-32.
  38. Koziol, J. A. Feng, A. C. Seasonal variations in exacerbations and MRI parameters in relapsing-remitting multiple sclerosis. Neuroepidemiology. 2004 Sep-Oct; 23 (5): 217-23.
  39. Kragt, J. van Amerongen, B. Killestein, J. Dijkstra, C. Uitdehaag, B. Polman, Ch Lips, P. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler. 2009 Jan; 15 (1): 9-15.
  40. Kurtzke, J. F. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev. 1993 Oct; 6 (4): 382-427.
  41. Levin, L. I. Munger, K. L. O’Reilly, E. J. Falk, K. I. Ascherio, A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol. 2010 Jun; 67 (6): 824-30.
  42. Mookherjee, N. Rehaume, L. M. Hancock, R. E. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin Ther Targets. 2007 Aug; 11 (8): 993-1004.
  43. Mowry, E. M. Krupp, L. B. Milazzo, M. Chabas, D. Strober, J. B. Belman, A. L. McDonald, J. C. Oksenberg, J. R. Bacchetti, P. Waubant, E. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010 May; 67 (5): 618-24.
  44. Munger, K. L. Levin, L. I. Hollis, B. W. Howard, N. S. Ascherio, A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 Dec 20; 296 (23): 2832-8.
  45. Niino, M. Vitamin D and its immunoregulatory role in multiple sclerosis. Drugs Today (Barc). 2010 Apr; 46 (4): 279-90.
  46. Noonan, C. W. Williamson, D. M. Henry, J. P. Indian, R. Lynch, S. G. Neuberger, J. S. Schiffer, R. Trottier, J. Wagner, L. Marrie, R. A. The prevalence of multiple sclerosis in 3 US communities. Prev Chronic Dis. 2010 Jan; 7 (1): A12.
  47. Oksenberg, J. R. Barcellos, L. F. Cree, B. A. Baranzini, S. E. Bugawan, T. L. Khan, O. Lincoln, R. R. Swerdlin, A. Mignot, E. Lin, L. Goodin, D. Erlich, H. A. Schmidt, S. Thomson, G. Reich, D. E. Pericak-Vance, M. A. Haines, J. L. Hauser, S. L. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet. 2004 Jan; 74 (1): 160-7.
  48. Panitch, H. S. Influence of infection on exacerbations of multiple sclerosis. Ann Neurol. 1994; 36 SupplS25-8.
  49. Pender, M. P. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection. Autoimmun Rev. 2009 Jun; 8 (7): 563-8.
  50. Pierrot-Deseilligny, C. Souberbielle, J. C. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?. Brain. 2010 Jul; 133 (Pt 7): 1869-88.
  51. Ramagopalan, S. V. Hanwell, H. E. Giovannoni, G. Knappskog, P. M. Nyland, H. I. Myhr, K. M. Ebers, G. C. Torkildsen, O. Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis. Arch Neurol. 2010 Aug; 67 (8): 1034-5.
  52. Ramagopalan, S. V. Knight, J. C. Ebers, G. C. Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol. 2009 Jun; 22 (3): 219-25.
  53. Ramagopalan, S. V. Maugeri, N. J. Handunnetthi, L. Lincoln, M. R. Orton, S. M. Dyment, D. A. Deluca, G. C. Herrera, B. M. Chao, M. J. Sadovnick, A. D. Ebers, G. C. Knight, J. C. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009 Feb; 5 (2): e1000369.
  54. Ramagopalan, S. V. Valdar, W. Dyment, D. A. DeLuca, G. C. Yee, I. M. Giovannoni, G. Ebers, G. C. Sadovnick, A. D. Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology. 2009; 32 (4): 257-62.
  55. Royal, W., 3rd Mia, Y. Li, H. Naunton, K. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J Neuroimmunol. 2009 Aug 18; 213 (1-2): 135-41.
  56. Simpson, S., Jr. Taylor, B. Blizzard, L. Ponsonby, A. L. Pittas, F. Tremlett, H. Dwyer, T. Gies, P. van der Mei, I. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010 Aug; 68 (2): 193-203.
  57. Sioka, C. Kyritsis, A. P. Fotopoulos, A. Multiple sclerosis, osteoporosis, and vitamin D. J Neurol Sci. 2009 Dec 15; 287 (1-2): 1-6.
  58. Smolders, J. Menheere, P. Thewissen, M. Peelen, E. Tervaert, J. W. Hupperts, R. Damoiseaux, J. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol. 2010 Jul; 121 (1-2): 243-6.
  59. Smolders, J. Thewissen, M. Peelen, E. Menheere, P. Tervaert, J. W. Damoiseaux, J. Hupperts, R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One. 2009; 4 (8): e6635.
  60. Soilu-Hanninen, M. Laaksonen, M. Laitinen, I. Eralinna, J. P. Lilius, E. M. Mononen, I. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008 Feb; 79 (2): 152-7.
  61. Solomon, A. J. Whitham, R. H. Multiple sclerosis and vitamin D: a review and recommendations. Curr Neurol Neurosci Rep. 2010 Sep; 10 (5): 389-96.
  62. Steffensen, L. H. Mellgren, S. I. Kampman, M. T. Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis. J Neurol. 2010 Mar; 257 (3): 410-8.
  63. Taylor, B. V. Lucas, R. M. Dear, K. Kilpatrick, T. J. Pender, M. P. van der Mei, I. A. Chapman, C. Coulthard, A. Dwyer, T. McMichael, A. J. Valery, P. C. Williams, D. Ponsonby, A. L. Latitudinal variation in incidence and type of first central nervous system demyelinating events. Mult Scler. 2010 Apr; 16 (4): 398-405.
  64. Tremlett, H. van der Mei, I. A. Pittas, F. Blizzard, L. Paley, G. Mesaros, D. Woodbaker, R. Nunez, M. Dwyer, T. Taylor, B. V. Ponsonby, A. L. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology. 2008; 31 (4): 271-9.
  65. Urashima, M. Segawa, T. Okazaki, M. Kurihara, M. Wada, Y. Ida, H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010 May; 91 (5): 1255-60.
  66. Wallin, M. T. Page, W. F. Kurtzke, J. F. Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol. 2004 Jan; 55 (1): 65-71.
  67. Wingate, P. J. McAulay, K. A. Anthony, I. C. Crawford, D. H. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection. J Med Virol. 2009 May; 81 (5): 870-7.